cpafenzy
Wednesday, March 2, 2016
Valeant appoints Ari Kellen executive vice president
(Reuters) - Valeant Pharmaceuticals International Inc said it appointed Ari Kellen executive vice president, succeeding Deb Jorn who has resigned, effective immediately.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment